Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma

The C-X-C chemokine receptor type 4 (CXCR4) is a pleiotropic chemokine receptor that is expressed in not only normal hematopoietic cells but also multiple myeloma cells. Its ligand, stromal cell-derived factor 1α (SDF-1α) is produced in the bone marrow microenvironment. The SDF-1α/CXCR4 axis plays a...

Full description

Bibliographic Details
Main Authors: Shigeki Ito, Tsuyoshi Sato, Takahiro Maeta
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/8/1793
_version_ 1797538278745833472
author Shigeki Ito
Tsuyoshi Sato
Takahiro Maeta
author_facet Shigeki Ito
Tsuyoshi Sato
Takahiro Maeta
author_sort Shigeki Ito
collection DOAJ
description The C-X-C chemokine receptor type 4 (CXCR4) is a pleiotropic chemokine receptor that is expressed in not only normal hematopoietic cells but also multiple myeloma cells. Its ligand, stromal cell-derived factor 1α (SDF-1α) is produced in the bone marrow microenvironment. The SDF-1α/CXCR4 axis plays a pivotal role in the major physiological processes associated with tumor proliferation, survival, invasion, dissemination, and drug resistance in myeloma cells. This review summarizes the pleiotropic role of the SDF-1α/CXCR4 axis in multiple myeloma and discusses the future perspective in the SDF-1α/CXCR4 axis-targeted therapies in multiple myeloma.
first_indexed 2024-03-10T12:29:16Z
format Article
id doaj.art-b66bef31a2374691af88bfcbec263931
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T12:29:16Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-b66bef31a2374691af88bfcbec2639312023-11-21T14:49:30ZengMDPI AGCancers2072-66942021-04-01138179310.3390/cancers13081793Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple MyelomaShigeki Ito0Tsuyoshi Sato1Takahiro Maeta2Division of Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba 028-3695, JapanDivision of Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba 028-3695, JapanDivision of Hematology & Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba 028-3695, JapanThe C-X-C chemokine receptor type 4 (CXCR4) is a pleiotropic chemokine receptor that is expressed in not only normal hematopoietic cells but also multiple myeloma cells. Its ligand, stromal cell-derived factor 1α (SDF-1α) is produced in the bone marrow microenvironment. The SDF-1α/CXCR4 axis plays a pivotal role in the major physiological processes associated with tumor proliferation, survival, invasion, dissemination, and drug resistance in myeloma cells. This review summarizes the pleiotropic role of the SDF-1α/CXCR4 axis in multiple myeloma and discusses the future perspective in the SDF-1α/CXCR4 axis-targeted therapies in multiple myeloma.https://www.mdpi.com/2072-6694/13/8/1793CXCR4SDF-1αmultiple myelomadrug resistanceextramedullary disease
spellingShingle Shigeki Ito
Tsuyoshi Sato
Takahiro Maeta
Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
Cancers
CXCR4
SDF-1α
multiple myeloma
drug resistance
extramedullary disease
title Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
title_full Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
title_fullStr Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
title_full_unstemmed Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
title_short Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma
title_sort role and therapeutic targeting of sdf 1α cxcr4 axis in multiple myeloma
topic CXCR4
SDF-1α
multiple myeloma
drug resistance
extramedullary disease
url https://www.mdpi.com/2072-6694/13/8/1793
work_keys_str_mv AT shigekiito roleandtherapeutictargetingofsdf1acxcr4axisinmultiplemyeloma
AT tsuyoshisato roleandtherapeutictargetingofsdf1acxcr4axisinmultiplemyeloma
AT takahiromaeta roleandtherapeutictargetingofsdf1acxcr4axisinmultiplemyeloma